Alteration of the Expression of Bcl-2, Bcl-x, Bax, Fas, and Fas Ligand in the Involved Skin of Psoriasis vulgaris following Topical Anthralin Therapy

Publisher: Karger

E-ISSN: 1660-5535|16|1|50-58

ISSN: 1660-5527

Source: Skin Pharmacology and Physiology, Vol.16, Iss.1, 2003-02, pp. : 50-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content